These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 12584870)

  • 1. Modified directly observed therapy (MDOT) for injection drug users with HIV disease.
    McCance-Katz EF; Gourevitch MN; Arnsten J; Sarlo J; Rainey P; Jatlow P
    Am J Addict; 2002; 11(4):271-8. PubMed ID: 12584870
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pilot study to enhance HIV care using needle exchange-based health services for out-of-treatment injecting drug users.
    Altice FL; Springer S; Buitrago M; Hunt DP; Friedland GH
    J Urban Health; 2003 Sep; 80(3):416-27. PubMed ID: 12930880
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiretroviral adherence and HIV treatment outcomes among HIV/HCV co-infected injection drug users: the role of methadone maintenance therapy.
    Palepu A; Tyndall MW; Joy R; Kerr T; Wood E; Press N; Hogg RS; Montaner JS
    Drug Alcohol Depend; 2006 Sep; 84(2):188-94. PubMed ID: 16542797
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Directly administered antiretroviral therapy in methadone clinics is associated with improved HIV treatment outcomes, compared with outcomes among concurrent comparison groups.
    Lucas GM; Mullen BA; Weidle PJ; Hader S; McCaul ME; Moore RD
    Clin Infect Dis; 2006 Jun; 42(11):1628-35. PubMed ID: 16652321
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Methadone dosing strategies in HIV-infected injection drug users enrolled in a directly observed therapy program.
    Tossonian HK; Raffa JD; Grebely J; Trotter B; Viljoen M; Mead A; Khara M; McLean M; Duncan F; Fraser C; DeVlaming S; Conway B
    J Acquir Immune Defic Syndr; 2007 Jul; 45(3):324-7. PubMed ID: 17468668
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessing limiting factors to the acceptance of antiretroviral therapy in a large cohort of injecting drug users.
    Clarke S; Delamere S; McCullough L; Hopkins S; Bergin C; Mulcahy F
    HIV Med; 2003 Jan; 4(1):33-7. PubMed ID: 12534957
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Time to initiating highly active antiretroviral therapy among HIV-infected injection drug users.
    Celentano DD; Galai N; Sethi AK; Shah NG; Strathdee SA; Vlahov D; Gallant JE
    AIDS; 2001 Sep; 15(13):1707-15. PubMed ID: 11546947
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A randomized clinical trial of community-based directly observed therapy as an adherence intervention for HAART among substance users.
    Macalino GE; Hogan JW; Mitty JA; Bazerman LB; Delong AK; Loewenthal H; Caliendo AM; Flanigan TP
    AIDS; 2007 Jul; 21(11):1473-7. PubMed ID: 17589194
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Directly observed antiretroviral therapy improves adherence and viral load in drug users attending methadone maintenance clinics: a randomized controlled trial.
    Berg KM; Litwin A; Li X; Heo M; Arnsten JH
    Drug Alcohol Depend; 2011 Jan; 113(2-3):192-9. PubMed ID: 20832196
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adherence and plasma HIV RNA responses to highly active antiretroviral therapy among HIV-1 infected injection drug users.
    Wood E; Montaner JS; Yip B; Tyndall MW; Schechter MT; O'Shaughnessy MV; Hogg RS
    CMAJ; 2003 Sep; 169(7):656-61. PubMed ID: 14517122
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of injecting drug use on response to highly active antiretroviral treatment in HIV-1-infected patients: a nationwide population-based cohort study.
    Larsen MV; Omland LH; Gerstoft J; Røge BT; Larsen CS; Pedersen G; Obel N; Kronborg G
    Scand J Infect Dis; 2010 Dec; 42(11-12):917-23. PubMed ID: 20840000
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The impact of methadone or buprenorphine treatment and ongoing injection on highly active antiretroviral therapy (HAART) adherence: evidence from the MANIF2000 cohort study.
    Roux P; Carrieri MP; Villes V; Dellamonica P; Poizot-Martin I; Ravaux I; Spire B;
    Addiction; 2008 Nov; 103(11):1828-36. PubMed ID: 18778390
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Directly administered antiretroviral therapy in an urban methadone maintenance clinic: a nonrandomized comparative study.
    Lucas GM; Weidle PJ; Hader S; Moore RD
    Clin Infect Dis; 2004 Jun; 38 Suppl 5():S409-13. PubMed ID: 15156431
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Directly observed antiretroviral therapy for injection drug users with HIV infection.
    Clarke S; Keenan E; Ryan M; Barry M; Mulcahy F
    AIDS Read; 2002 Jul; 12(7):305-7, 312-6. PubMed ID: 12161852
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Psychosocial determinants of adherence to highly active antiretroviral therapy among injection drug users in Vancouver.
    Kerr T; Palepu A; Barness G; Walsh J; Hogg R; Montaner J; Tyndall M; Wood E
    Antivir Ther; 2004 Jun; 9(3):407-14. PubMed ID: 15259903
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Directly observed antiretroviral therapy in substance abusers receiving methadone maintenance therapy does not cause increased drug resistance.
    Brust JC; Litwin AH; Berg KM; Li X; Heo M; Arnsten JH
    AIDS Res Hum Retroviruses; 2011 May; 27(5):535-41. PubMed ID: 20854173
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Harm reduction intensity-Its role in HAART adherence amongst drug users in Amsterdam.
    Lambers FA; Stolte IG; van den Berg CH; Coutinho RA; Prins M
    Int J Drug Policy; 2011 May; 22(3):210-8. PubMed ID: 21392958
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adherence among women with HIV infection in Puerto Rico: the potential use of modified directly observed therapy (MDOT) among pregnant and postpartum women.
    Ciambrone D; Loewenthal HG; Bazerman LB; Zorilla C; Urbina B; Mitty JA
    Women Health; 2006; 44(4):61-77. PubMed ID: 17456464
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interaction of methadone with didanosine and stavudine.
    Rainey PM; Friedland G; McCance-Katz EF; Andrews L; Mitchell SM; Charles C; Jatlow P
    J Acquir Immune Defic Syndr; 2000 Jul; 24(3):241-8. PubMed ID: 10969348
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Delay in the initiation of HAART, poorer virological response, and higher mortality among HIV-infected injecting drug users in Spain.
    Rodríguez-Arenas MA; Jarrín I; del Amo J; Iribarren JA; Moreno S; Viciana P; Peña A; Sirvent JL; Vidal F; Lacruz J; Gutierrez F; Oteo JA; Asencio R; Castilla J; Hoyos SP;
    AIDS Res Hum Retroviruses; 2006 Aug; 22(8):715-23. PubMed ID: 16910826
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.